Literature DB >> 26853121

Diastereoselective 1,3-Dipolar Cycloadditions of N,N'-Cyclic Azomethine Imines with Iminooxindoles for Access to Oxindole Spiro-N,N-bicyclic Heterocycles.

Hong-Wu Zhao1, Bo Li1, Hai-Liang Pang1, Ting Tian1, Xiao-Qin Chen1, Xiu-Qing Song1, Wei Meng1, Zhao Yang1, Yu-Di Zhao1, Yue-Yang Liu1.   

Abstract

In the presence of CuI, 1,3-dipolar cycloadditions of N,N'-cyclic azomethine imines with iminooxindoles proceeded readily and furnished novel oxindole spiro-N,N-bicyclic heterocycles in moderate to excellent chemical yields with excellent diastereoselectivities.

Entities:  

Year:  2016        PMID： 26853121     DOI： 10.1021/acs.orglett.6b00139

Source DB:  PubMed          Journal:  Org Lett        ISSN： 1523-7052            Impact factor:   6.005


  4 in total

1.  Synthesis of Spirobicyclic Pyrazoles by Intramolecular Dipolar Cycloadditions/[1s, 5s] Sigmatropic Rearrangements.

Authors:  Christine A Dimirjian; Marta Castiñeira Reis; Edward I Balmond; Nolan C Turman; Elys P Rodriguez; Michael J Di Maso; James C Fettinger; Dean J Tantillo; Jared T Shaw
Journal:  Org Lett       Date:  2019-09-05       Impact factor: 6.005

2.  1,3-Dipolar cycloaddition of isatin N,N'-cyclic azomethine imines with α,β-unsaturated aldehydes catalyzed by DBU in water.

Authors:  Zhan-Yong Wang; Ting Yang; Rongxiang Chen; Xueji Ma; Huan Liu; Kai-Kai Wang
Journal:  RSC Adv       Date:  2020-06-25       Impact factor: 4.036

3.  Cycloaddition of Huisgen 1,4-dipoles: synthesis and rapid epimerization of functionalized spiropyrido[2,1-b][1,3]oxazine-pyrroles and related products.

Authors:  Andrew R Galeev; Anna A Moroz; Maksim V Dmitriev; Andrey N Maslivets
Journal:  RSC Adv       Date:  2021-12-22       Impact factor: 3.361

4.  Asymmetric Synthesis of Bicyclic Pyrazolidinones through Alkaloid-Catalyzed [3+2]-Cycloadditions of Ketenes and Azomethine Imines.

Authors:  Mukulesh Mondal; Shubhanjan Mitra; Dylan J Twardy; Manashi Panda; Kraig A Wheeler; Nessan J Kerrigan
Journal:  Chemistry       Date:  2022-03-14       Impact factor: 5.020
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.